Advanced biomaterials for human glioblastoma multiforme (GBM) drug delivery
Glioblastoma multiforme (GBM) has several distinctive characteristics linked to a poor early-
stage prognosis. The crucial obstacle in the treatment of GBM is the inability of chemo drugs …
stage prognosis. The crucial obstacle in the treatment of GBM is the inability of chemo drugs …
Hydrogel Applications in the Diagnosis and Treatment of Glioblastoma
S Zhang, R Zhong, MR Younis, H He… - … Applied Materials & …, 2024 - ACS Publications
Glioblastoma multiforme (GBM), a common malignant neurological tumor, has boundaries
indistinguishable from those of normal tissue, making complete surgical removal ineffective …
indistinguishable from those of normal tissue, making complete surgical removal ineffective …
Glioblastoma-targeted, local and sustained drug delivery system based on an unconventional lipid nanocapsule hydrogel
C Gazaille, E Bozzato, N Madadian-Bozorg… - Biomaterials …, 2023 - Elsevier
The objective of this work was to develop an implantable therapeutic hydrogel that will
ensure continuity in treatment between surgery and radiochemotherapy for patients with …
ensure continuity in treatment between surgery and radiochemotherapy for patients with …
Development and characterization of lipid nanocapsules loaded with iron oxide nanoparticles for magnetic targeting to the blood–brain barrier
J Aparicio-Blanco, C Pucci, D De Pasquale… - Drug Delivery and …, 2024 - Springer
Brain drug delivery is severely hindered by the presence of the blood–brain barrier (BBB). Its
functionality relies on the interactions of the brain endothelial cells with additional cellular …
functionality relies on the interactions of the brain endothelial cells with additional cellular …
Advances in Hydrogels of Drug Delivery Systems for the Local Treatment of Brain Tumors
J Yang, Z Wang, C Ma, H Tang, H Hao, M Li, X Luo… - Gels, 2024 - mdpi.com
The management of brain tumors presents numerous challenges, despite the employment of
multimodal therapies including surgical intervention, radiotherapy, chemotherapy, and …
multimodal therapies including surgical intervention, radiotherapy, chemotherapy, and …
Supramolecular hydrogels enable co-delivery of chemotherapeutics with synergistic efficacy against patient-derived glioblastoma cells and spheroids
RJ Cavanagh, S Baquain, C Alexander… - RSC …, 2024 - pubs.rsc.org
Drug combinations have been shown to be highly effective in many cancer therapies but the
ratios of the individual drugs must be adjusted carefully and formulated appropriately to …
ratios of the individual drugs must be adjusted carefully and formulated appropriately to …
Lipid Nanocapsules: Latest Advances and Applications
J Aparicio-Blanco, AI Torres-Suárez - Fundamentals of Pharmaceutical …, 2024 - Springer
Lipid nanocapsules (LNCs) are core-shell structures composed of an oily liquid triglyceride
core surrounded by a surfactant rigid membrane. LNCs are versatile carriers that can be …
core surrounded by a surfactant rigid membrane. LNCs are versatile carriers that can be …
Systemic and local immune responses to glioblastoma surgery help tailoring combinatory regimens
C Bastiancich, E Snacel-Fazy, S Fernandez, S Robert… - 2024 - researchsquare.com
Glioblastoma (GBM), an incurable brain tumor, necessitates surgery followed by
chemoradiation, but recurrences remain fatal. While regenerative responses post-tumor …
chemoradiation, but recurrences remain fatal. While regenerative responses post-tumor …